TNFRSF4 and neoplasm: Regarding the surveillance of activated T cells that infiltrate the tumor after immunotherapy, for example, binding to OX40 on activated Tregs could be considered a potential limitation, since not only anti-tumor effector T cells are visualized by hOX40-Nb.